Publication: Prevalence and risk factors associated with the occurrence of autoimmune diseases in patients with alopecia areata
Issued Date
2021-01-01
Resource Type
ISSN
11787031
Other identifier(s)
2-s2.0-85115777266
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Inflammation Research. Vol.14, (2021), 4881-4891
Suggested Citation
Kumutnart Chanprapaph, Thipprapai Mahasaksiri, Chaninan Kositkuljorn, Kanchana Leerunyakul, Poonkiat Suchonwanit Prevalence and risk factors associated with the occurrence of autoimmune diseases in patients with alopecia areata. Journal of Inflammation Research. Vol.14, (2021), 4881-4891. doi:10.2147/JIR.S331579 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77342
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Prevalence and risk factors associated with the occurrence of autoimmune diseases in patients with alopecia areata
Other Contributor(s)
Abstract
Background: Increased rates of autoimmune diseases (ADs) have been reported in association with alopecia areata (AA); however, the risk factors for coexisting ADs in AA patients have been poorly investigated. Objective: To evaluate the prevalence and factors associated with AD comorbidities in patients with AA. Methods: This case–control study included patients diagnosed with AA between January 2000 and March 2020. Individuals with AA, both with and without concomitant ADs, were statistically compared. Variables significantly associated with coexisting ADs were identified using univariate and multivariate logistic regression analyses. Multinomial logistic regression analysis was performed to identify the specific risk factors for each concomitant AD. Results: Among the 615 patients with AA, comorbid ADs were found in 76 (12.4%). Autoimmune thyroid disease (AITD) exhibited the highest frequency (n = 42, 6.8%), followed by vitiligo (n = 15, 2.4%), and systemic lupus erythematosus (SLE) (n = 12, 2.0%). Logistic regression analyses revealed that female sex (odds ratio [OR] = 2.45, 95% confidence interval [CI] = 1.24–4.82; P = 0.011), nail abnormalities (OR = 2.49, 95% CI = 1.14–5.46; P = 0.023), and atopic diseases (OR = 1.98, 95% CI = 1.09–2.43; P < 0.001) were significantly associated with coexisting ADs. Regarding each concomitant AD, nail abnormalities were an associated factor for AITD (OR = 4.65, 95% CI = 1.96–7.24; P = 0.01), whereas coexisting atopic diseases were demonstrated as a predictor of vitiligo (OR = 2.48, 95% CI = 1.43–4.58; P = 0.02). Female sex (OR = 1.61, 95% CI = 1.18–4.27; P = 0.04) and family history of AD (OR = 1.85, 95% CI = 1.26–4.19; P = 0.03) were predictors of SLE. Conclusion: This study suggests that female AA patients with nail abnormalities and atopic diseases have increased rates of AD comorbidities. A thorough review of systems for associated factors can help physicians screen for concomitant ADs.